Enovis Corporation (ENOV)
NYSE: ENOVHealth CareIndustrial SpecialtiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ENOV stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.47B
- Forward P/E
- 7.35
- EPS (TTM)
- -$9.23
- Dividend yield
- None
- 52-week range
- 16.70 – 31.67
- Day range
- 25.39 – 26.62
- Volume / Avg
- 1.22M / 1.71M
- Beta
- —
- Shares outstanding
- 57.69M
52-week range
ENOV stock today
Shares of Enovis (ENOV) finished lower on Nov 20 at $25.47, a drop of 2.90% or $0.76 per share, versus the S&P 500's 3.70% decline. At this level, ENOV sits in the middle of its 52-week range of $16.70 to $31.67: 19.6% below the high, set on Aug 4, 2026 and 52.5% above the low. ENOV is down 4.4% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 11.5%.
Enovis has posted a net loss over the last twelve months (EPS of -$9.23), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Enovis
Company profileEnovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions.
- Sector
- Health Care
- Industry
- Industrial Specialties
- CEO
- Mr. Damien McDonald
- Headquarters
- Lewisville, TX
- Employees
- 7,802
- Website
- enovis.com
Financial highlights
Full financialsIn fiscal 2025, Enovis generated $2.25 billion in revenue, up 6.7% from fiscal 2024, its 5th consecutive year of revenue growth. Enovis reported a net loss of $1.18 billion, compared with a loss of $825.5 million a year earlier. Gross margin was 59.8% (up from 56.0%) and operating margin -50.0%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $2.25B | $2.11B | $1.71B | $1.56B | $1.43B |
| Growth | +6.66% | +23.46% | +9.22% | +9.60% | +27.26% |
| Net income | $-1.18B | $-825.49M | $-33.26M | $-13.29M | $71.66M |
| EPS (diluted) | $-20.75 | $-14.93 | $-0.61 | $-0.25 | $1.40 |
Analyst forecast
ForecastConsensus (13 analysts)
strong_buy
Avg. price target
$37.83+48.53%
- Strong buy 2
- Buy 10
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 5, 2026
- EPS actual vs est.
- $0.06 vs $0.64
- Surprise
- -90.63%
ENOV news
All ENOV news- Enovis to Present at the Annual Jefferies Global Healthcare Concerence in LondonGlobeNewswire
- Enovis Corp (ENOV) Q3 2026 Earnings Call TranscriptNasdaq
- Enovis Corporation Non-GAAP EPS of $0.88 beats by $0.11, revenue of $558.7M beats by $1.55MSeeking Alpha
- ENOVIS Announces Third Quarter 2026 ResultsGlobeNewswire
- Enovis Corporation Q3 2026 Earnings PreviewSeeking Alpha
- Enovis to Host Third Quarter 2026 Results Conference Call on November 5thGlobeNewswire
Enovis peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| DSGRDistribution Solutions Group Inc. | 35.00 | -0.09% | $1.62B | vs ENOV |
| TRSTriMas Corporation | 36.77 | -2.52% | $1.30B | vs ENOV |
| CDRECadre Holdings Inc. | 29.45 | -3.63% | $1.26B | vs ENOV |
| XPELXPEL Inc. | 38.12 | +1.36% | $1.05B | vs ENOV |
| FOILLondian Wason New Energy Tech Inc. ADR | 12.30 | -11.95% | $969.05M | vs ENOV |
| WLFCWillis Lease Finance Corporation | 41.96 | -2.31% | $957.23M | vs ENOV |
| ESTAEstablishment Labs Holdings Inc. | 69.14 | -0.68% | $2.06B | vs ENOV |
| ADSEADS-TEC ENERGY PLC | 9.78 | +3.82% | $735.32M | vs ENOV |
Indexes, lists and sector
Enovis stock FAQ
What is Enovis's stock price today?
ENOV last traded at $25.47 as of Nov 20, 4:00 PM EST, down 2.90% on the day. Prices are delayed at least 15 minutes.
Does Enovis pay a dividend?
No. Enovis does not currently pay a regular cash dividend.
Who is Enovis's CEO?
Mr. Damien McDonald is the chief executive officer of Enovis Corporation, which has about 7,802 employees.
Has ENOV ever split its stock?
Yes. The most recent ENOV stock split was a 581-for-1000 split on Apr 5, 2022.
What is the ENOV 52-week high?
The 52-week high for ENOV is $31.67 and the 52-week low is $16.70. The stock is currently 19.6% below its high.